Bowman & Company’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
11,566
+4,512
| +64% | +$394K | 0.45% | 59 |
|
|
2025
Q1 | $482K | Buy |
7,054
+1,535
| +28% | +$105K | 0.24% | 78 |
|
|
2024
Q4 | $429K | Sell |
5,519
-1,158
| -17% | -$90K | 0.22% | 78 |
|
|
2024
Q3 | $448K | Buy |
6,677
+753
| +13% | +$50.5K | 0.23% | 76 |
|
|
2024
Q2 | $672K | Buy |
5,924
+527
| +10% | +$59.8K | 0.39% | 69 |
|
|
2024
Q1 | $749K | Buy |
+5,397
| New | +$749K | 0.45% | 66 |
|